Analysen von Ryan Martins
| 03.05.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 02.05.11 | Celgene overweight | Barclays Capital | |
| 02.05.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 28.04.11 | Celgene overweight | Barclays Capital | |
| 27.04.11 | Amgen overweight | Barclays Capital | |
| 20.04.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 18.04.11 | Human Genome Sciences overweight | Barclays Capital | |
| 14.04.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
|
Werbung
|
|||
| 12.04.11 | Rigel Pharmaceuticals overweight | Barclays Capital | |
| 12.04.11 | Celgene overweight | Barclays Capital | |
| 30.03.11 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 17.03.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 16.03.11 | Celgene overweight | Barclays Capital | |
| 15.03.11 | Halozyme Therapeutics overweight | Barclays Capital | |
| 14.03.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 03.03.11 | Ziopharm Oncology overweight | Barclays Capital | |
| 03.03.11 | Rigel Pharmaceuticals overweight | Barclays Capital | |
| 02.03.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 02.03.11 | Ionis Pharmaceuticals overweight | Barclays Capital | |
| 24.02.11 | Ziopharm Oncology overweight | Barclays Capital | |
| 24.02.11 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 21.02.11 | Ariad Pharmaceuticals overweight | Barclays Capital | |
| 18.02.11 | Amgen overweight | Barclays Capital | |
| 15.02.11 | Regeneron Pharmaceuticals overweight | Barclays Capital | |
| 09.02.11 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 07.02.11 | Celgene overweight | Barclays Capital | |
| 04.02.11 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 03.02.11 | Array BioPharma overweight | Barclays Capital | |
| 31.01.11 | Celgene overweight | Barclays Capital | |
| 27.01.11 | Celgene overweight | Barclays Capital | |
| 26.01.11 | Amgen overweight | Barclays Capital | |
| 25.01.11 | Amgen overweight | Barclays Capital | |
| 13.01.11 | Amgen overweight | Barclays Capital | |
| 12.01.11 | Celgene overweight | Barclays Capital | |
| 16.12.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 15.12.10 | Amgen overweight | Barclays Capital | |
| 13.12.10 | Amgen overweight | Barclays Capital | |
| 09.12.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 08.12.10 | Celgene overweight | Barclays Capital | |
| 01.12.10 | Amgen overweight | Barclays Capital | |
| 22.11.10 | Amgen overweight | Barclays Capital | |
| 16.11.10 | Human Genome Sciences overweight | Barclays Capital | |
| 08.11.10 | Ionis Pharmaceuticals overweight | Barclays Capital | |
| 05.11.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 27.10.10 | Amgen overweight | Barclays Capital | |
| 20.10.10 | Amgen overweight | Barclays Capital | |
| 11.10.10 | Onyx Pharmaceuticals overweight | Barclays Capital | |
| 07.10.10 | Halozyme Therapeutics overweight | Barclays Capital | |
| 27.09.10 | Amylin Pharmaceuticals overweight | Barclays Capital | |
| 22.09.10 | Amgen overweight | Barclays Capital | |